Samorita Hospital Limited announcements
287 Dhaka Stock Exchange announcements for Samorita Hospital Limited (SAMORITA) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2021 (20).
- Confirmation of share transfer by a Sponsor Director
Dr. A. B. M. Haroon, one of the Sponsor Directors of the Company, has further reported that he has completed his transfer 1,00,000 shares of the Company to his son Mr. Md. Atiqul Basher (General Shareholder), by way of gift outside the trading system of the Exchange as per declaration disseminated on 12.12.2021.
- Declaration of share transfer by a Sponsor Director
Dr. A. B. M. Haroon, one of the Sponsor Directors of the Company, has expressed his intention to transfer his 1,00,000 shares out of his total holding 15,05,354 shares of the Company to his son Mr. Md. Atiqul Basher (General Shareholder), by way of gift outside the trading system of the Exchange within next 30 working days from the date of issuance of approval letter by DSE.
- Resumption after record date
Trading of the shares of the Company will resume on 24.11.2021 after record date.
- Suspension for Record date
Trading of the shares of the Company will remain suspended on record date i.e., 23.11.2021 for EGM & AGM.
- Spot News for EGM & AGM
Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 21.11.2021 to 22.11.2021. Trading of the shares of the Company will remain suspended on record date i.e., 23.11.2021 for EGM & AGM.
- Share Transmission of Deceased Independent Directors� among his succes
The Company has informed that Prof. S.A.M. Golam Kibria, one of the Independent Directors of the company passed away on 05.06.2020. His total holding of 26,904 shares will be transmitted among his successors according to the Succession Certificate issued by the Honorable Court.
- The Board of Directors has recommended 10% cash dividend for the year ended on June 30, 2021. The Board of Directors has
The Board of Directors has recommended 10% cash dividend for the year ended on June 30, 2021. The Board of Directors has also decided in the said meeting to increase the Authorized Share Capital of the company from Tk. 20.00 crore to Tk. 50.00 crore by amending the Clause-V of the Memorandum of Association and Article- 5 of the Articles of Association of the Company, subject to the approval of the shareholders in the 3rd Extra ordinary General Meeting (EGM) of the company as special Resolution. (cont.)
- (Continuation news of SAMORITA): Reason for significant deviation: Operating result in the reporting period has been sig
(Continuation news of SAMORITA): Reason for significant deviation: Operating result in the reporting period has been significantly increased due to the following reasons, compared to previous corresponding period: i) Revenue has been increased by Tk. 2.69 crore for treatment of more covid patients. ii) Cost of direct materials has been decreased from 42.92% to 39.49%. (cont. 2)
The first part of this announcement is missing from the archive. - (Continuation news of SAMORITA): iii) Administrative expenses has been decreased from 48.10% to 37.65% of revenue. NOCFP
(Continuation news of SAMORITA): iii) Administrative expenses has been decreased from 48.10% to 37.65% of revenue. NOCFPS increased from Tk. 1.01 in September 2020 to Tk. 1.57 in September 2021 due to cash received from customers has been increased by Tk. 2.32 crore. (end)
The first part of this announcement is missing from the archive. - Dividend Declaration & increase of authorized capital
(Continuation news of SAMORITA): Date of EGM & AGM: 29.12.2021, Time of EGM and AGM: 11:00 AM and 11:30 AM respectively, Venue: Digital Platform. Record Date for EGM & AGM: 23.11.2021. The Company has reported EPS of Tk. 2.23, NAV per share of Tk. 51.46 and NOCFPS of Tk. 3.18 for the year ended on June 30, 2021 as against Tk. 0.17, Tk. 49.23 and Tk. 0.64 respectively for the same period of the previous year. (end)
The first part of this announcement is missing from the archive. - Price Limit Open
There will be no price limit on the trading of the shares of the Company on today (31.10.2021) for following its corporate declaration.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 1.08 for July-September 2021 as against Tk. 0.34 for July-September 2020; NOCFPS was Tk. 1.57 for July-September 2021 as against Tk. 1.01 for July-September 2020. NAV per share was Tk. 52.54 as on September 30, 2021 and Tk. 51.46 as on June 30, 2021. (cont. 1)
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 30, 2021 at 11:00 AM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2021.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 30, 2021 at 11:00 AM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2021.
- Construction of 08 Storied building and Other
(cont. of SAMORITA): The entire amount will be financed from own source of the company. It was also decided in the meeting that two building purchased recently adjacent to hospital premises will be let-out for residential purpose after some renovation works until any other decision is taken. The estimated renovation cost will be BDT 40,00,000.00 and estimated monthly rent of BDT. 1,70,000.00. (end)
The first part of this announcement is missing from the archive. - Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.23 for January-March 2021 as against Tk. 0.12 for January-March 2020; EPS was Tk. 1.58 for July 2020-March 2021 as against Tk. 1.19 for July 2019-March 2020. NOCFPS was Tk. 2.88 for July 2020-March 2021 as against Tk. 1.79 for July 2019-March 2020. NAV per share was Tk. 50.81 as on March 31, 2021 and Tk. 49.23 as on June 30, 2020.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 27, 2021 at 2:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2021.
- Decision to land purchase
(Continuation news of SAMORITA): The entire amount will be financed by the Southeast Bank Ltd., Dhanmondi Branch, Dhaka. The property will be used for future expansion of hospital services. (end)
The first part of this announcement is missing from the archive. - Q2 Financials
(Q2 Un-audited): EPS was Tk. 1.01 for October-December 2020 as against Tk. 0.18 for October-December 2019, EPS was Tk. 1.35 for July-December 2020 as against Tk. 1.07 for July-December 2019. NOCFPS was Tk. 2. 47 for July-December 2020 as against Tk. 1.01 for July-December 2019. NAV per share was Tk. 50.58 as on December 31, 2020 and Tk. 49.23 as on June 30, 2020.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 27, 2021 at 6:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2020.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.